Utama › Kanser Prostat › Washington › Spokane Valley
Kajian klinikal Kanser Prostat di Spokane Valley, WA
9 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Spokane Valley (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Mengambil pesertaFasa 3
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi jauh
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi jauh
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Mengambil pesertaFasa 3
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi jauh
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi jauh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi jauh
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi jauh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi jauh
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi jauh
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Mengambil pesertaFasa 3
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi jauh
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi jauh
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Mengambil pesertaFasa 3
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi jauh
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi jauh
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Mengambil pesertaFasa 2
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi jauh
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi jauh
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Mengambil pesertaFasa 3
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi jauh
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi jauh
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 3
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi jauh
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di Spokane Valley
- Kanser Paru-paru Bukan Sel Kecil14 kajian
- Kanser Paru-paru8 kajian
- Kanser Payudara8 kajian
- Leukemia Mieloid Akut7 kajian
- Melanoma6 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher4 kajian
- Kanser Metastatik4 kajian
- Kanser Kolorektal4 kajian
- Kanser Kolon4 kajian
- Kanser (semua jenis)4 kajian
- Kanser Pundi Kencing4 kajian
- Kanser Endometrium3 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.